Investment case
Dentsply Sirona Inc.
XRAY · 6 developments mapped · last assessed 2026-09-17
Market Ontology has mapped 6 macro, policy, and market developments to Dentsply Sirona Inc. since 2026-09-09. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for XRAY yet, so no modelled value is shown. The XRAY valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run XRAY on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Strongest support
Dentsply Sirona Beats Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY26 Outlook
Direct financial performance exceeding expectations and reaffirmed guidance signaling stability.
· Moves eps growth rate, future revenue growth, profitability outlook
- Open question
Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms Full-Year 2026 Guidance
Direct earnings report, beating EPS expectations but with revenue decline and maintained guidance.
· Moves near term growth rates, profitability outlook, analyst consensus revisions
What changed, by assumption
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY26 Outlook
- 2026-09-09Dentsply Sirona Beats Q2 Adjusted EPS Consensus at $0.52 and Reaffirms FY26 Outlook
- 2026-09-09Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 Guidance
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms Full-Year 2026 Guidance
- 2026-09-09Dentsply Sirona reports Q2 adjusted EPS of $0.52 and maintains $3.5B-$3.6B sales outlook
- 2026-09-17Envista Holdings Corporation Hosts 2026 Investor Day
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-17 | Envista Holdings Corporation Hosts 2026 Investor Day | watch | 1-3m | 0.40 |
| 2026-09-09 | Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms Full-Year 2026 Guidance | mixed | 1-3m | 0.70 |
| 2026-09-09 | Dentsply Sirona Beats Q2 Adjusted EPS Consensus at $0.52 and Reaffirms FY26 Outlook | mixed | 1-3m | 0.70 |
| 2026-09-09 | Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 Guidance | mixed | 1-3m | 0.70 |
| 2026-09-09 | Dentsply Sirona Beats Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY26 Outlook | Bullish | 1-3m | 0.80 |
| 2026-09-09 | Dentsply Sirona reports Q2 adjusted EPS of $0.52 and maintains $3.5B-$3.6B sales outlook | Bullish | 1-3m | 0.70 |